Doctor profile · Federal record
Dr. Manpreet Singh, Physicians Assistant
Physician Assistant · Las Vegas, NV
- NPI 1205172186
- Accepts Medicare
- MIPS 77.9 / 100 · 2023
- 14 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
2650 N Tenaya Way Ste 208
Las Vegas, NV 891281104
(702) 360-2100
fax (702) 360-3201 - Mailing address
-
2285 Corporate Cir Ste 200
Henderson, NV 890747759
Credentials & registration
- NPI registered
- December 2012 — 14 yrs on file
- Profile last updated
- January 5, 2022
- Year of graduation
- 2012 — 14 yrs since
- Specialty taxonomy
- 363A00000X — NUCC code
- State license (1)
- Nevada #PA2468
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1205172186. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
953
Distinct HCPCS
10
Medicare allowed
$51,668
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 271 | 41 | $6 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 149 | 95 | $76 | |
17110 |
Destruction of skin growth, 1-14 growths | 109 | 68 | $97 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 102 | 102 | $94 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 102 | 66 | $48 | |
17000 |
Destruction of precancer skin growth, 1 growth | 93 | 62 | $44 | |
11102 |
Biopsy of related skin growth, first growth | 46 | 44 | $82 | |
99202 |
New patient office or other outpatient visit, 15-29 minutes | 34 | 34 | $61 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 29 | 23 | $108 | |
11103 |
Biopsy of related skin growth, each additional growth | 18 | 14 | $43 |
In context: peer comparison
Among 130 peers in Las Vegas Physician Assistant, average services per provider: 127. This provider delivers 7.5× the peer median.Open Payments
Industry payments received
All-time total
$1,402
Transactions
52
Manufacturers
12
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Abbvie INC. | 17 | $341.46 | |
| Janssen Biotech, INC. | 10 | $315.14 | |
| Sun Pharmaceutical Industries INC. | 3 | $149.49 | |
| Genzyme Corporation | 5 | $133.98 | |
| Novartis Pharmaceuticals Corporation | 5 | $100.17 | |
| Regeneron Healthcare Solutions, INC. | 1 | $98.35 | |
| Dermavant Sciences, INC. | 4 | $63.12 | |
| E.R. Squibb & Sons, L.L.C. | 1 | $61.86 | |
| Leo Pharma INC. | 3 | $61.82 | |
| Lilly USA, LLC | 1 | $31.71 | |
| Pfizer INC. | 1 | $22.64 | |
| Organon LLC | 1 | $22.17 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
921
Patients
630
Total drug cost
$110,415
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Ketoconazole | Generic | 191 | 117 | $3,541 |
| Triamcinolone Acetonide | Generic | 154 | 118 | $2,093 |
| Doxycycline Monohydrate | Generic | 87 | 60 | $2,109 |
| Clobetasol Propionate | Generic | 86 | 52 | $4,573 |
| Hydrocortisone | Generic | 69 | 56 | $655 |
| Betamethasone Diprop Augmented (Betamethasone/Propylene Glyc) | Brand | 64 | 48 | $2,069 |
| Mupirocin | Generic | 63 | 52 | $394 |
| Ammonium Lactate | Generic | 62 | 51 | $1,272 |
| Metronidazole | Generic | 31 | 25 | $2,312 |
| Dupixent Pen (Dupilumab) | Brand | 22 | 0 | $84,981 |
Frequently asked questions
What is Dr. Manpreet Singh's medical specialty?
Dr. Manpreet Singh practices Physician Assistant in Las Vegas, NV.
Where does Dr. Manpreet Singh practice?
Dr. Manpreet Singh practices at 2650 N Tenaya Way Ste 208, Las Vegas, NV 891281104. Office phone: 7023602100.
What is Dr. Manpreet Singh's NPI?
Dr. Manpreet Singh's National Provider Identifier (NPI) is 1205172186, issued by NPPES.
Does Dr. Manpreet Singh accept Medicare assignment?
Yes. Dr. Manpreet Singh accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Manpreet Singh commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of skin growth, 1-14 growths (HCPCS 17110). Source: CMS Medicare Physician & Other Practitioners file.